Clinical Trial Update: Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexmedetomidine's effect on phenylephrine response in refractory septic shock has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Phenylephrine (phenylephrine)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Septic Shock, Vasopressor Resistance | Phase 3 | Status: TERMINATED